Patients with systemic lupus erythematosus in remission for five or more years are at a lower risk of cardiovascular disease…
Articles by Joana Carvalho, PhD
CareFirst BlueCross BlueShield and Exagen Diagnostics are collaborating on a study to assess the impact of the AVISE Lupus test,…
A type of immune cell found in the outer layer of the skin, called Langerhans cells, seem to be essential…
Baricitinib — a medicine approved in the U.S., Europe, and Japan for rheumatoid arthritis — can significantly improve symptoms of systemic lupus…
A team of scientists from the University of California San Francisco has developed an innovative technique to genetically engineer genes…
Researchers found that controlling the activity of Tbet, the main transcription factor of inflammatory T-cells, reduces kidney inflammation and tissue…
Pain disturbs sleep and can augment depression, two factors that directly impact cognition in people with systemic lupus erythematosus, according…
Baricitinib, a medicine approved in the U.S., Europe and Japan for rheumatoid arthritis, significantly improved the clinical outcomes of systemic…